Pyridoxine Deficiency After Solid Organ Transplant.

Area of Science:

• Transplantation Medicine
• Nutritional Science
• Immunology

Background:

• Pyridoxine (vitamin B6) is crucial for immune function.
• Low pyridoxine levels may impact outcomes in solid organ transplant recipients.
• Identifying risk factors for pyridoxine deficiency is essential in this vulnerable population.

Purpose of the Study:

• To assess risk factors for low pyridoxine levels in solid organ transplant recipients.
• To investigate the association between immunosuppression and pyridoxine status.
• To determine the prevalence of pyridoxine deficiency in this cohort.

Main Methods:

• Cohort study comparing patients with normal and low pyridoxine levels.
• Collection of dietary, clinical, and immunosuppression data.
• Statistical analysis including descriptive statistics, correlation, and multivariate logistic regression.

Main Results:

• 29 out of 48 (60%) transplant recipients had low pyridoxine levels.
• Thymoglobulin treatment (for induction or rejection) was strongly correlated with low pyridoxine levels (OR=19.5).
• Multivariate analysis confirmed thymoglobulin treatment as the only significant independent risk factor for pyridoxine deficiency.

Conclusions:

• Low pyridoxine levels are common in solid organ transplant recipients.
• Thymoglobulin administration is significantly associated with pyridoxine deficiency.
• Further prospective studies are needed to confirm these findings and assess clinical significance.